After a five-year investigation, the HHS Office of Research Integrity announced that it has settled with former Duke University researcher Anil Potti.
MD Anderson Cancer Center entered into a collaboration with CytomX Therapeutics to research Probody-enabled chimeric antigen receptor natural killer cell therapies, to be known as ProCAR-NK cell therapies. MD Anderson will develop allogeneic umbilical cord blood and peripheral blood derived NK-cell therapies and combine it with CytomX’s Probody technology to address new targets for this […]
FDA granted Breakthrough Therapy Designation to pexidartinib (formerly PLX3397) for the treatment of tenosynovial giant cell tumor where surgical removal of the tumor would be associated with potentially worsening functional limitation or severe morbidity. Currently, there is no FDA-approved systemic therapy for the treatment of TGCT. The designation was granted based on results from an […]
Researchers from The Cancer Genome Atlas Network recently published two studies—one identifying seven distinct molecular subtypes of prostate cancer, and one exploring the genetic drivers of papillary renal cell carcinoma.
EDITH PEREZ was named vice president and head of Genentech/Roche BioOncology U.S. Medical Affairs. Perez stepped down as vice chair of the Alliance for Clinical Trials in Oncology.
THE AMERICAN ASSOCIATION FOR CANCER RESEARCH launched an international genomic and clinical data sharing initiative, known as AACR Project Genomics, Evidence, Neoplasia, Information, Exchange—or GENIE. The initial phase of the project, which is being conducted in partnership with seven global leaders in genomic sequencing for clinical utility as well as two informatics partners, will aggregate […]
NCI is taking applications for its Research Specialist Award, which is designed to encourage the development of stable research career opportunities for scientists who want to pursue research within the context of an existing cancer research program, but not serve as independent investigators.
NCI recognized 11 investigators nationwide with its Cancer Clinical Investigator Team Leadership Awards. The awards support clinical investigators at NCI-designated cancer centers who participate in NCI-funded clinical trials. Established in 2009, the awards are intended to help retain investigators in academic clinical research careers. The award provides partial salary support for 2 years for the […]
STAND UP TO CANCER, Cancer Research UK and the Lustgarten Foundation selected members for a Dream Team focused on pancreatic cancer. Daniel Von Hoff, physician-in-chief and distinguished professor at the Translational Genomics Research Institute in Phoenix, chief scientific officer at HonorHealth, and professor of medicine at the Mayo Clinic, will lead the team—with Ronald Evans, […]
NCI awarded eight new, competing and renewed grants as part of its funding for its Specialized Programs of Research Excellence. The grantees will receive $2,185,000 per year for five years.
